This detox phase may usher in mild symptoms
In one randomized controlled trial, 114 participants were given ipamorelin intravenously (rather than by subcutaneous injection) to see if it could speed up their digestive tracts after major bowel surgery
Now, we don't know exactly how much overlap exists between heavy drinkers and GLP-1 users, but given that this group consumes thousands of extra liquid calories per week, I think it's reasonable to assume high rates of overweight and obesity in this group
GLP-1 agonists produce dramatic weight loss (averaging 15-20% total body weight) primarily through central appetite suppression, eliminating hunger and creating pharmaceutical satiety
Console L, Scalise M, Mazza T, Pochini L, Galluccio M, Giangregorio N, et al